Home › Spinal Muscular Atrophy › Texas › Houston
Spinal Muscular Atrophy clinical trials in Houston, TX
5 studies for Spinal Muscular Atrophy are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
RecruitingPhase 2
- Texas Children's Hospital (TCH)-Clinical Care Center (CCC), Houston
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
RecruitingPhase 2
- Texas Children's Hospital, Houston
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
RecruitingPhase 1
- Texas Childrens Hospital Houston, Houston
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Recruiting
- Texas Children's Hospital, Houston
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
RecruitingObservational study
- Texas Children's Hospital, Houston
About Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) attacks nerve cells in the spinal cord, weakening voluntary muscles. Read about the genetics, types, and what may help.
More about Spinal Muscular Atrophy on MedlinePlus
Spinal Muscular Atrophy trials in other cities
- Mountain View, CA9 studies
- New York City, NY9 studies
- Philadelphia, PA7 studies
- Chicago, IL6 studies
- Norfolk, VA6 studies
- Grand Rapids, MI6 studies
- Boston, MA5 studies
- Little Rock, AR4 studies
- Lewisville, TX4 studies
- Phoenix, AZ4 studies
- Aurora, CO4 studies
- Memphis, TN3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.